
Deborah Anne Fisher MD MHS (She/Her)
Inflammatory Bowel Disease
Associate Vice President, Medical Affairs, Gastroenterology
Join to view full profile
1500 Harding StIndianapolis, IN 46221
Fax+1 919-416-5839
Dr. Fisher is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Deborah Fisher is a gastroenterologist and Associate Vice President in Medical Affairs at Eli Lilly and Company. She received her medical degree from Vanderbilt University School of Medicine and was in academic practice at Duke University for 20 years. She is experienced in endoscopy, clinical research, and health services research. She has more than 100 publications and over 500 citings.
Education & Training
Duke University HospitalFellowship, Gastroenterology, 1999 - 2002
University of Virginia Medical CenterResidency, Internal Medicine, 1996 - 1999
Vanderbilt University School of MedicineClass of 1996
Certifications & Licensure
NC State Medical License 1999 - 2022
VA State Medical License 1998 - 2000
Awards, Honors, & Recognition
- FACG American College of Gastroenterology, 2010
- Fellow (AGAF) American Gastroenterological Association, 2011
- Fellow (FASGE) American Society of Gastrointestinal Endoscopy, 2010
Publications & Presentations
PubMed
- Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study.Scott D Lee, Severine Vermeire, Ryan Ungaro, Aisha Vadhariya, Frederick Durand
The American Journal of Gastroenterology. 2025-03-13 - 8 citationsAssociation of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction)...Millie D Long, Stefan Schreiber, Toshifumi Hibi, Theresa Hunter Gibble, Deborah A Fisher
Crohn's & Colitis 360. 2024-01-01 - 3 citationsAcid exposure time is sensitive for detecting gastroesophageal reflux disease and is associated with long-term survival after lung transplant.Nancy Y Yang, Alice Parish, Shai Posner, Rahul A Shimpi, Richard K Wood
Diseases of the Esophagus. 2023-07-27
Authored Content
- Guidelines for Sedation and Anesthesia in GI EndoscopyJanuary 2018
- Guidelines for Sedation and Anesthesia in GI EndoscopyJanuary 2018
Press Mentions
Duke Researchers Develop 'Smart Toilet' That Monitors Bowel HealthMay 24th, 2021
’Smart Toilet’ Uses Artificial Intelligence to Monitor Bowel HealthMay 24th, 2021
Scientists Invent Smart Toilet That Sends Poop Data to Your DoctorMay 24th, 2021
Grant Support
- Understanding recommendations for screening colonoscopy intervalsNIDDK2013–Present
- Colorectal Cancer Screening Behavior In The VA PopulatioNational Cancer Institute2006
- Colorectal Cancer Screening Behavior In VA PopulationNational Cancer Institute2005
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









